Forskolin rescues hypoxia-induced cognitive dysfunction in zebrafish with potential involvement of O -GlcNAc cycling regulation

Quynh T.N. Nguyen,Jiwon Park,Dong Yeol Kim,Duong T. Tran,Inn Oc Han
DOI: https://doi.org/10.1016/j.bcp.2024.116032
IF: 6.1
2024-01-28
Biochemical Pharmacology
Abstract:Repeated sublethal hypoxia exposure induces brain inflammation and affects the initiation and progression of cognitive dysfunction. Experiments from the current study showed that hypoxic exposure downregulates PKA/CREB signaling, which is restored by forskolin (FSK), an adenylate cyclase activator, in both Neuro2a (N2a) cells and zebrafish brain. FSK significantly protected N2a cells from hypoxia-induced cell death and neurite shrinkage. Intraperitoneal administration of FSK for 5 days on zebrafish additionally led to significant recovery from hypoxia-induced social interaction impairment and learning and memory (L/M) deficit. FSK suppressed hypoxia-induced neuroinflammation, as indicated by the observed decrease in NF-κB activation and GFAP expression. We further investigated the potential effect of FSK on O -GlcNAcylation changes induced by hypoxia. Intriguingly FSK induced marked upregulation of the protein level of O -GlcNAc transferase catalyzing addition of the GlcNAc group to target proteins, accompanied by elevated O -GlcNAcylation of nucleocytoplasmic proteins. The hypoxia-induced O -GlcNAcylation decrease in the brain of zebrafish was considerably restored following FSK treatment. Based on the collective results, we propose that FSK rescues hypoxia-induced cognitive dysfunction, potentially through regulation of HBP/ O -GlcNAc cycling.
pharmacology & pharmacy
What problem does this paper attempt to address?